Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03320889 · ClinicalTrials.gov registry record · NA

Hepatitis C Education for Pregnant Women With Opiate Dependence - Phase 2

A NA study of Hepatitis C, sponsored by TriHealth.

Completed
Registry status
NA
Development phase
115
Enrollment target
1
Study location

NCT03320889 is a NA study of Hepatitis C that has completed, run by TriHealth. The registered enrollment target is 115 participants, below the 1,889-participant average among 106 other Hepatitis C trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03320889, a NA study of Hepatitis C, has completed, sponsored by TriHealth.

COMPLETED
Registry status
NA
Development phase
115 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to assess patients' attitudes and knowledge of Hepatitis C, analyze the variables that may influence patients' knowledge, and educate patients on Hepatitis C.

Conditions Studied

Interventions

  • OTHER Educational Intervention

Study Locations (1)

Ohio

  • Good Samaritan Hospital - Cincinnati

Trial Details

FieldValue
Enrollment Target 115 participants
Start Date 2017-10-30
Est. Completion 2019-08-26
Phase NA

Sponsor

TriHealth

81 total trials

What the Registry Record Tells You About NCT03320889

The ClinicalTrials.gov registry entry for NCT03320889 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,889-participant average among 106 other Hepatitis C trials with a reported enrollment target (94% lower). The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hepatitis C appearing as the primary indexed condition, and to 1 intervention - of which Educational Intervention is the first listed.

NCT03320889 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT03320889 about?

NCT03320889 is a clinical study titled "Hepatitis C Education for Pregnant Women With Opiate Dependence - Phase 2". The goal of this study is to assess patients' attitudes and knowledge of Hepatitis C, analyze the variables that may influence patients' knowledge, and educate patients on Hepatitis C.

What is the current status of trial NCT03320889?

This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2017-10-30. Estimated completion is 2019-08-26.

What conditions does trial NCT03320889 study?

This clinical trial studies the following conditions: Hepatitis C.

What interventions are being tested in trial NCT03320889?

The interventions under investigation include: Educational Intervention (OTHER).

Who is sponsoring clinical trial NCT03320889?

This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03320889 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hepatitis C

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.